Changchun Hi-Tech (000661.SZ): Currently, the company's long-acting liquid agent is the only growth hormone product approved for sale in China
Gelonghui, Feb. 20 | Changchun Hi-Tech (000661.SZ) said on the investor interactive platform that currently the company's long-acting liquid agent is the only growth hormone product approved for sale in China, and there are other companies' products approved for sale in powder and water products.
Express News | Continue to increase repurchases from nearly 100 companies in Shenzhen
Changchun Hi-Tech (000661.SZ): The total cost of the repurchase was about 120 million yuan to repurchase 986,600 shares
Gelonghui, January 25, 丨 Changchun Hi-Tech (000661.SZ) announced that the company's initial share repurchase period was January 24, 2024. A total of 986,600 shares of the company's shares were repurchased through a dedicated securities account, accounting for 0.24% of the company's total share capital. The highest transaction price was 123.2 yuan/share, and the lowest transaction price was 118.86 yuan/share. The total transaction amount was approximately RMB 120 million (including transaction fees). At this point, the company's current repurchase plan has been fully implemented.
Express News | The wave of buybacks to increase holdings continues, and another batch of listed companies stepped forward
Express News | Changchun Hi-Tech: Plans to repurchase the company's shares for 100 million yuan to 120 million yuan
Changchun Hi-Tech (000661.SZ): Injectable GenSci125 independently developed for Jinsai Pharmaceutical
Gelonghui, January 19 | Changchun Hi-Tech (000661.SZ) said on the investor interactive platform that injectable GenSci 125 was independently developed by Jinsai Pharmaceutical and is the first injectable long-term progesterone weekly preparation approved by the FDA for clinical research.